Verrica Pharmaceuticals annual revenue
2021
2022
2023
2024
2025
Verrica Pharmaceuticals Revenue Growth & History (VRCA)
Verrica Pharmaceuticals reported $35.6M in revenue for fiscal 2025, an increase of 370.22% from the previous fiscal year.
View full Verrica Pharmaceuticals company overviewVerrica Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $35.6M | $28.0M | +370.22% |
| 2024 | 2024-12-31 | $7.6M | $2.4M | +47.66% |
| 2023 | 2023-12-31 | $5.1M | −$3.9M | −43.27% |
| 2022 | 2022-12-31 | $9.0M | −$3.0M | −24.73% |
| 2021 | 2021-12-31 | $12.0M | — | — |
Verrica Pharmaceuticals quarterly revenue
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.9M | −$6.8M | −53.85% |
| Q1 2026 | 2026-03-31 | $5.0M | $1.6M | +46.06% |
| Q4 2025 | 2025-12-31 | $5.1M | $4.7M | +1380.23% |
| Q3 2025 | 2025-09-30 | $14.3M | $16.1M | +905.39% |
| Q2 2025 | 2025-06-30 | $12.7M | $7.5M | +145.35% |
| Q1 2025 | 2025-03-31 | $3.4M | −$387,000 | −10.12% |
| Q4 2024 | 2024-12-31 | $344,000 | — | — |
| Q3 2024 | 2024-09-30 | −$1.8M | −$4.7M | −161.06% |
| Q2 2024 | 2024-06-30 | $5.2M | $5.0M | +2744.51% |
| Q1 2024 | 2024-03-31 | $3.8M | $3.8M | +10240.54% |
| Q3 2023 | 2023-09-30 | $2.9M | −$5.4M | −64.94% |
| Q2 2023 · Jun 30 | 2023-06-30 | $182,000 | −$32,000 | −14.95% |
| Q1 2023 | 2023-03-31 | $37,000 | −$394,000 | −91.42% |
| Q4 2022 | 2022-12-31 | $68,000 | $68,000 | — |
| Q3 2022 | 2022-09-30 | $8.3M | $8.3M | — |
| Q2 2022 | 2022-06-30 | $214,000 | $214,000 | — |
| Q1 2022 | 2022-03-31 | $431,000 | −$11.6M | −96.41% |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $12.0M | — | — |
Verrica Pharmaceuticals revenue growth trends
Verrica Pharmaceuticals's latest reported quarter, Q2 2026, generated $5.9M in revenue, a decrease of 53.85% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Verrica Pharmaceuticals source filings ↗